Helsinki Business and Science Park (HBSP) provides a dynamic business environment with a diversified research and expert network and a Centre of Expertise within biotechnology, drug development and diagnostics, as well as food and environmental technology. Our objective is to improve the success opportunities of Finnish companies on the international market, and to improve domestic competitiveness.
03/11/2008
Prove-it™ Sepsis assay provides critical information for early antimicrobial treatment review by identifying the sepsis causing pathogens significantly earlier than current diagnostics.